花旗:上调新东方在线(1797.HK)目标价55%至48港元 评级“买入”
花旗发表研究报告将新东方在线(1797.HK)投资评级由“中性”上调至“买入”,因为公司K12双教师大型线上课程以及东方优播小型线上课程模式,将在2021财年看到成果,而且大学线上教育课程也可能会有所恢复。公司将新东方在线新的目标价调升55%至48港元,因其与母公司的协同效应会更多显现。
花旗报告将新东方在线2020财年公司收入增加18%,主要归功于K12线上教育实现了85%的增长,而且在后六个月的增长更为强劲,预计这个暑期报名大型线上课程的学生达到了100万左右,按年增加100%,东方优播覆盖的城市也进一步增加,将公司2021-22财年的收入预测上调7-11%。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.